Home › Therapeutic areas › Hematology
Hematology (11 companies · 9 conditions)
Conditions
Companies
| Ticker | Company | Therapeutic areas | In Hematology | Lead stage | Programs |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | HematologyOphthalmologyRenalRespiratory Rare | 1 | Approved | 14 |
| ANNX | Annexon, Inc. | HematologyNeurologyOphthalmologyRenal Rare | 1 | NDA Submitted | 6 |
| BEAM | Beam Therapeutics Inc. | HematologyMetabolicRespiratory Rare | 1 | Phase 1 | 8 |
| CLYM | Climb Bio, Inc. | HematologyImmunologyRenal Rare | 1 | Phase 2 | 7 |
| COGT | Cogent Biosciences, Inc. | HematologyOncology Rare | 1 | NDA Submitted | 7 |
| FBIO | Fortress Biotech, Inc. | DermatologyHematologyMetabolic Rare | 1 | Approved | 14 |
| IMMX | Immix Biopharma, Inc. | Hematology Rare | 1 | Phase 2 | 1 |
| OMER | OMEROS CORP | HematologyNeurologyOncologyRespiratory Rare | 1 | NDA Submitted | 7 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | CardiovascularHematologyImmunology Rare | 0 | Approved | 4 |
| QURE | uniQure N.V. | HematologyMetabolicNeurology Rare | 1 | Approved | 6 |
| VNDA | Vanda Pharmaceuticals Inc. | CardiovascularDermatologyGI/HepatologyHematologyImmunologyInfectious DiseaseNeurologyOphthalmology Rare | 1 | Approved | 26 |
No companies match.